Carcinogenesis Advance Access originally published online on March 28, 2006
Carcinogenesis 2006 27(9):1787-1796; doi:10.1093/carcin/bgl021
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
H1 histamine receptor antagonists induce genotoxic and caspase-2-dependent apoptosis in human melanoma cells
Department of Cell Biology and Histology, Faculty of Medicine and Dentistry, University of the Basque Country Leioa E-48940, Vizcaya, Spain
1 Department of Medicine and Pharmacology, Faculty of Medicine, University of Salahaddin Kurdistan-Iraq
2 Department of Dermatology, Cruces Hospital Baracaldo E-48903, Vizcaya, Spain
*To whom correspondence should be addressed. Tel: +34 94 601 5689; Fax: +34 94 601 3266; Email: lola.boyano{at}ehu.es
Previously, we found that the H1 histamine receptor antagonist diphenhydramine induces apoptosis in human acute T-lymphocytic leukemia cells. Since histamine has been shown to act as a growth factor in malignant melanoma cells, we decided to evaluate the in vitro effect of diphenhydramine and other H1 histamine receptor antagonists, such as terfenadine, astemizol and triprolidine on four malignant human melanoma cell lines. These antagonists were found to induce apoptotic cell death in all four melanoma cell lines. Apoptosis was determined by assessment of phosphatidylserine exposure on the surface of the cells and nuclear fragmentation. Importantly, H1 antagonist treatments did not adversely affect the viability of human melanocytes and murine fibroblasts at the same doses and duration of exposure. Treatment of melanoma cells with terfenadine induced DNA damage and caspases 2, 3, 6, 8 and 9 activation. Furthermore, the general caspase inhibitor (z-VAD-FMK) and a selective inhibitor of caspase-2 (z-VDVAD-FMK) protected melanoma cells from terfenadine-induced apoptosis. In contrast, the caspase-8 inhibitor (z-IETD-FMK) was ineffective. In addition, we found that mitochondria are involved in TEF-induced apoptosis, characterized by the dissipation of the mitochondrial transmembrane potential, the release of cytochrome c into the cytosolic compartment and caspase-9 activation. On the basis of these results we conclude that H1 histamine receptor antagonists induce apoptosis in human melanoma cells but not in normal melanocytes and embryonic murine fibroblasts; this apoptosis appears to be caspase-2-dependent and involves the mitochondrial pathway. The present results may contribute to the elaboration of novel therapeutic strategies for the treatment of malignant human melanoma.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H. Francis, S. Glaser, S. DeMorrow, E. Gaudio, Y. Ueno, J. Venter, D. Dostal, P. Onori, A. Franchitto, M. Marzioni, et al. Small mouse cholangiocytes proliferate in response to H1 histamine receptor stimulation by activation of the IP3/CaMK I/CREB pathway Am J Physiol Cell Physiol, August 1, 2008; 295(2): C499 - C513. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Scheurer, R. El-Zein, P. A. Thompson, K. D. Aldape, V. A. Levin, M. R. Gilbert, J. S. Weinberg, and M. L. Bondy Long-term Anti-inflammatory and Antihistamine Medication Use and Adult Glioma Risk Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1277 - 1281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-M. Jangi, M.B. Ruiz-Larrea, F. Nicolau-Galmes, N. Andollo, Y. Arroyo-Berdugo, I. Ortega-Martinez, J. L. Diaz-Perez, and M. D. Boyano Terfenadine-induced apoptosis in human melanoma cells is mediated through Ca2+ homeostasis modulation and tyrosine kinase activity, independently of H1 histamine receptors Carcinogenesis, March 1, 2008; 29(3): 500 - 509. [Abstract] [Full Text] [PDF]
|
|